ATE243993T1 - Verwendung von 5ht3 antagonisten zum fördern der darmspülung - Google Patents

Verwendung von 5ht3 antagonisten zum fördern der darmspülung

Info

Publication number: ATE243993T1
Authority: AT; Austria
Prior art keywords: antagonists; flushment; promote intestinal; intestinal; promote
Prior art date: 1997-04-18

Application number

AT98922759T

Other languages

English (en)

Inventor

Antonius Adrianus Hendr Megens

Original Assignee

Janssen Pharmaceutica Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-04-18

Filing date

1998-04-14

Publication date

2003-07-15

1998-04-14 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv

2003-07-15 Application granted granted Critical

2003-07-15 Publication of ATE243993T1 publication Critical patent/ATE243993T1/de

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

AT98922759T 1997-04-18 1998-04-14 Verwendung von 5ht3 antagonisten zum fördern der darmspülung ATE243993T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP97201149		1997-04-18
PCT/EP1998/002356 WO1998047481A1 (en)	1997-04-18	1998-04-14	Use of 5ht3 antagonists for promoting intestinal lavage

Publications (1)

Publication Number	Publication Date
ATE243993T1 true ATE243993T1 (de)	2003-07-15

Family

ID=8228223

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT98922759T ATE243993T1 (de)	1997-04-18	1998-04-14	Verwendung von 5ht3 antagonisten zum fördern der darmspülung

Country Status (12)

Country	Link
US (2)	US6235745B1 (de)
EP (1)	EP0975327B1 (de)
JP (1)	JP2001523239A (de)
KR (1)	KR100529512B1 (de)
AT (1)	ATE243993T1 (de)
AU (1)	AU745361B2 (de)
CA (1)	CA2286076C (de)
DE (1)	DE69816060T2 (de)
DK (1)	DK0975327T3 (de)
ES (1)	ES2202855T3 (de)
PT (1)	PT975327E (de)
WO (1)	WO1998047481A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1090638A1 (de) *	1999-10-08	2001-04-11	Sanofi-Synthelabo	Verwendung von (R)-Zacopride oder dessen Salz zur Herstellung eines Medikaments für die Behandlung von Schlafapnoe
US20040096423A1 (en) *	2000-11-24	2004-05-20	Megens Antonius Adrianus Hendrikus Petrus	Use of a triple combination comprising a 5ht3 antagonist, a 5ht4agonist and a laxative for promoting intestinal lavage
PE20021019A1 (es)	2001-04-19	2002-11-13	Upjohn Co	Grupos azabiciclicos sustituidos
US20040048874A1 (en) *	2001-05-22	2004-03-11	Bardsley Hazel Judith	New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine
GB0216027D0 (en) *	2002-07-10	2002-08-21	Arachnova Therapeutics Ltd	New therapeutic use
TWI332943B (en) *	2001-07-10	2010-11-11	Synta Pharmaceuticals Corp	Taxol enhancer compounds
US6946149B2 (en) *	2002-04-30	2005-09-20	Braintree Laboratories, Inc.	Salt solution for colon cleansing
EP1549645A1 (de) *	2002-10-01	2005-07-06	Johnson & Johnson Pharmaceutical Research & Development, Inc.	4,6-diaminosubstituierte-2-[oxy oder aminoxy]-[1,3,5]triazin als protein tyrosin kinase inhibitoren
US6996500B2 (en) *	2002-10-30	2006-02-07	Hewlett-Packard Development Company, L.P.	Method for communicating diagnostic data
BRPI0406749A (pt) *	2003-01-13	2005-12-20	Dynogen Pharmaceuticals Inc	Métodos relacionados ao tratamento de distúrbios fincionais do intestino e composição farmacêutica
ATE359079T1 (de) *	2003-01-13	2007-05-15	Dynogen Pharmaceuticals Inc	Verfahren zur behandlung von übelkeit, erbrechen, würgereiz oder jede kombination daraus
ATE365554T1 (de) *	2003-04-04	2007-07-15	Dynogen Pharmaceuticals Inc	Methode zur behandlung von erkrankungen der unteren harnwege
US7049319B2 (en) *	2003-09-23	2006-05-23	Semaan Abboud	Colon cleansing composition and method
US20070155780A1 (en) *	2004-04-15	2007-07-05	Hitoshi Nakata	Stabilized composition containing 4-amino-5-chloro-n-[(1r, 3r, 5s)-8-methyl-8-azabicyclo[3.2.1]oct-3-y1]-2-[1-methylbut-2-ynyloxy]benzamide
US20060293309A1 (en) *	2005-03-28	2006-12-28	Dynogen Pharmaceuticals, Inc.	Method of treating disorders and conditions using peripherally-restricted antagonists and inhibitors
WO2007019888A2 (en) *	2005-08-12	2007-02-22	Ctg Pharma S.R.L.	Therapeutic compositions containing mesalamine and a co-agent for treating colon diseases
RU2433822C2 (ru) *	2005-08-16	2011-11-20	Синта Фармасьютиклз Корп.	Композиция бис(тио-гидразид амида)
JP2009506069A (ja) *	2005-08-26	2009-02-12	ブレインセルス，インコーポレイティド	ムスカリン性受容体調節による神経発生
US7553846B2 (en)	2006-08-07	2009-06-30	Albany Molecular Research, Inc.	2-alkylbenzoxazole carboxamides as 5-HT3 modulators
AU2007281678B2 (en) *	2006-08-07	2012-08-02	Albany Molecular Research, Inc.	2-aminobenzoxazole carboxamides as 5HT3 modulators
US9545446B2 (en)	2013-02-25	2017-01-17	Synergy Pharmaceuticals, Inc.	Agonists of guanylate cyclase and their uses
RS59667B1 (sr)	2013-03-15	2020-01-31	Braintree Laboratories Inc	Oralna farmaceutska kompozicija sulfatnih soli u obliku tableta dvostruke primene i postupci njihove upotrebe
US10172833B2 (en)	2015-08-11	2019-01-08	Insys Development Company, Inc.	Sublingual ondansetron spray
US10143656B1 (en)	2017-08-04	2018-12-04	Braintree Laboratories, Inc.	Solid oral sulfate salt formulations for cleaning a colon and methods of using same
US11970483B2 (en)	2018-09-28	2024-04-30	Takeda Pharmaceutical Company Limited	Heterocyclic compound

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB893267A (en)	1958-11-25	1962-04-04	Sterling Drug Inc	Laxative enemas
US5166145A (en) *	1990-09-10	1992-11-24	Alza Corporation	Antiemetic therapy
TW294595B (de)	1992-11-20	1997-01-01	Janssen Pharmaceutica Nv
US6103734A (en)	1994-11-04	2000-08-15	Legarda Ibanez; Juan Jose	Drug combination as a medicament to suppress the dependence of individuals to opiates
WO1996014071A1 (es)	1994-11-04	1996-05-17	Legarda Ibanez Juan Jose	Combinacion de farmacos como medicamento destinado a supresion de dependencia de individuos a opiaceos
US5576317A (en) *	1994-12-09	1996-11-19	Pfizer Inc.	NK-1 receptor antagonists and 5HT3 receptor antagonists for the treatment of emesis

1998
- 1998-04-14 DE DE69816060T patent/DE69816060T2/de not_active Expired - Lifetime
- 1998-04-14 WO PCT/EP1998/002356 patent/WO1998047481A1/en active IP Right Grant
- 1998-04-14 AU AU75282/98A patent/AU745361B2/en not_active Ceased
- 1998-04-14 KR KR10-1999-7007936A patent/KR100529512B1/ko not_active IP Right Cessation
- 1998-04-14 PT PT98922759T patent/PT975327E/pt unknown
- 1998-04-14 ES ES98922759T patent/ES2202855T3/es not_active Expired - Lifetime
- 1998-04-14 JP JP54502298A patent/JP2001523239A/ja not_active Ceased
- 1998-04-14 EP EP98922759A patent/EP0975327B1/de not_active Expired - Lifetime
- 1998-04-14 US US09/403,248 patent/US6235745B1/en not_active Expired - Lifetime
- 1998-04-14 CA CA002286076A patent/CA2286076C/en not_active Expired - Lifetime
- 1998-04-14 AT AT98922759T patent/ATE243993T1/de not_active IP Right Cessation
- 1998-04-14 DK DK98922759T patent/DK0975327T3/da active
2001
- 2001-03-08 US US09/801,978 patent/US6555546B2/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
KR100529512B1 (ko)	2005-11-22
DE69816060D1 (de)	2003-08-07
DE69816060T2 (de)	2004-04-22
DK0975327T3 (da)	2003-10-20
ES2202855T3 (es)	2004-04-01
US20010020025A1 (en)	2001-09-06
WO1998047481A1 (en)	1998-10-29
EP0975327B1 (de)	2003-07-02
PT975327E (pt)	2003-11-28
AU745361B2 (en)	2002-03-21
CA2286076C (en)	2006-12-12
CA2286076A1 (en)	1998-10-29
US6235745B1 (en)	2001-05-22
US6555546B2 (en)	2003-04-29
JP2001523239A (ja)	2001-11-20
AU7528298A (en)	1998-11-13
EP0975327A1 (de)	2000-02-02
KR20000075858A (ko)	2000-12-26

Legal Events

Date

Code

Title

Description

2004-04-15

UEP

Publication of translation of european patent specification

Ref document number: 0975327

Country of ref document: EP

2011-01-15

REN

Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
ATE243993T1 (de)	2003-07-15	Verwendung von 5ht3 antagonisten zum fördern der darmspülung
DE69819311D1 (de)	2003-12-04	Neue benzimidazol inhibitoren der fructose-1,6-bisphosphatase
TR200000782T2 (tr)	2000-09-21	Resorsinol türevleri.
PT1140944E (pt)	2004-01-30	Derivados de epotilona e sua utilizacao como agentes antitumorais
FI964004A0 (fi)	1996-10-04	Serotoniiniantagonistien (5HT3) käyttö fibromyalgian hoitoon
PT892780E (pt)	2003-02-28	Analogos de m-amidino fenilo como inibidores do factor xa
CU22997A3 (es)	2004-10-12	Proteína híbrida para la inhibición de la desgranulación de los mastocitos y su utilización
TR970073A2 (tr)	1997-02-21	Alfa adrenerjik resentör antagonistleri olarak pirimidindion pirimidintrion,triazindion, tetrahidrokinazolindion türevleri.
EA199900693A1 (ru)	2000-02-28	Атропизомеры 3-арил-4(3h)-хиназолинонов и их использование в качестве антагонистов амра-рецепторов
PT1083903E (pt)	2004-11-30	Indenopirrolocarbazoles em ponte
SE9702773D0 (sv)	1997-07-22	Novel compounds
AR016981A2 (es)	2001-08-01	Polipeptidos sinteticos
TR200002896T2 (tr)	2001-01-22	Kalsilitik Bileşimler
DE3866309D1 (de)	1992-01-02	Laktonmodifizierte mannich-basen als dispergier-zusaetze, verwendbar in oeligen zusammensetzungen.
DE69804198T2 (de)	2002-10-02	Zementschlamm für die zementierung von bohrlöchern insbesondere ölbohrlöchern
DE69114328D1 (de)	1995-12-14	Überwachung von Mikroprozessoren.
EA200100517A1 (ru)	2001-12-24	Антагонисты 5ht1 для антидепрессантной терапии
TR200102742T2 (tr)	2002-05-21	Rezorsinol türevleri
NO882054D0 (no)	1988-05-11	Sementblanding, saerlig til bruk i borehull.
DE3873278D1 (de)	1992-09-03	Aryl-substituierte thiophen-3-ole, ihre derivate und analoge als lipoxygenase-inhibitoren.
PE20399A1 (es)	1999-03-05	Muteina ob
ATE213236T1 (de)	2002-02-15	Substituierte benzyloxyimino-verbindungen
TR200003203T2 (tr)	2001-03-21	Karboksaldehitin saflaştırılması
ATE238791T1 (de)	2003-05-15	Verwendung von 2-methyl-thiazolidin-2,4- dicarbonsäure als mukolytikum
TR199902605T2 (xx)	2000-02-21	Fibrinojenin azalt�lma y�ntemleri.